Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Adaptimmune Ther Ads (ADAP)

Adaptimmune Ther Ads (ADAP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adaptimmune Ther Ads 60 JUBILEE AVENUE MILTON PARK OXFORDSHIRE ABINGDON X0 OX14 4RX GBR

P: 44-12-3543-0000

Description:

Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 1,048,679
Shares Outstanding, K 130,109
Annual Sales, $ 1,120 K
Annual Net Income, $ -137,170 K
Last Quarter Sales, $ 760 K
Last Quarter Net Income, $ -28,170 K
60-Month Beta 2.33
% of Insider Shareholders 18.89%
% of Institutional Shareholders 72.13%
Float, K 105,531
% Float 81.11%

Growth:

1-Year Return 293.10%
3-Year Return 57.73%
5-Year Return -43.87%
5-Year Revenue Growth -89.58%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/06/20
Earnings Per Share ttm -1.31
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ADAP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -13.76
Price/Earnings to Growth N/A
Return-on-Equity % -85.62%
Return-on-Assets % -60.32%
Profit Margin % -12,247.32
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 1,011.19
Price/Cash Flow N/A
Price/Book 6.10
Book Value/Share 1.43
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar